Product Details
Synonym
Cadherin-17, CDH17, HPT-1, LI-cadherin
Source
Human Cadherin-17 (450-566) Protein, Fc Tag (CA7-H5255) is expressed from human 293 cells (HEK293). It contains AA Glu 450 - Phe 566 (Accession # Q12864-1).
Predicted N-terminus: Glu 450
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 39.1 kDa. The protein migrates as 43-55 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in 20 mM Tris, 150 mM NaCl, pH8.0 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Human Cadherin-17 (450-566) Protein, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Human Cadherin-17 (450-566) Protein, Fc Tag (Cat. No. CA7-H5255) is more than 90% and the molecular weight of this protein is around 80-105 kDa verified by SEC-MALS.
Report
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Cadherin-17
- Category:
- Approved Drugs:
0 Details
- Drugs in Clinical Trials:
17 Details
- Highest Development Stage:
Phase 2 Clinical




















